Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

New oral anticoagulants in elderly patients with atrial fibrillation.

Deedwania PC.

Am J Med. 2013 Apr;126(4):289-96. doi: 10.1016/j.amjmed.2012.10.012. Epub 2013 Jan 28. Review.

PMID:
23369212
2.

Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.

Dogliotti A, Paolasso E, Giugliano RP.

Clin Cardiol. 2013 Feb;36(2):61-7. doi: 10.1002/clc.22081. Epub 2013 Jan 21. Review.

3.

The need for new oral anticoagulants in clinical practice.

Hylek EM.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. Review.

PMID:
19571764
4.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
5.

Practical considerations for using novel oral anticoagulants in patients with atrial fibrillation.

Savelieva I, Camm AJ.

Clin Cardiol. 2014 Jan;37(1):32-47. doi: 10.1002/clc.22204. Epub 2013 Nov 19. Review.

6.

Anticoagulation in the elderly.

Henderson MC, White RH.

Curr Opin Pulm Med. 2001 Sep;7(5):365-70. Review.

PMID:
11584191
7.

An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.

Deedwania P, Huang GW.

Rev Cardiovasc Med. 2012;13(2-3):e89-104. Review.

PMID:
23160166
8.

Oral anticoagulant therapy in patients with atrial fibrillation.

Pengo V.

Semin Vasc Med. 2003 Aug;3(3):333-8. Review.

PMID:
15199467
9.

Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.

Garcia DA.

Thromb Res. 2012 Jan;129(1):9-16. doi: 10.1016/j.thromres.2011.09.023. Epub 2011 Oct 21. Review.

PMID:
22018997
10.

New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.

Garcia DA, Lopes RD, Hylek EM.

Thromb Haemost. 2010 Dec;104(6):1099-105. doi: 10.1160/TH10-07-0491. Epub 2010 Sep 30. Review.

PMID:
20886196
11.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
12.

Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.

Overvad TF, Larsen TB, Albertsen IE, Rasmussen LH, Lip GY.

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1619-29. doi: 10.1586/14779072.2013.839214. Review.

PMID:
24215192
13.
14.

Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.

Deitelzweig S.

Cardiovasc Ther. 2014 Apr;32(2):74-81. doi: 10.1111/1755-5922.12048. Review.

PMID:
24119252
15.

Bleeding risk factors affecting warfarin therapy in the elderly with atrial fibrillation.

Darnell SW, Davis SC, Whitcomb JJ, Manfredi JA, McLaurin BT.

Dimens Crit Care Nurs. 2014 Mar-Apr;33(2):57-63. doi: 10.1097/DCC.0000000000000022. Review.

PMID:
24496251
16.

Personalizing oral anticoagulant treatment in patients with atrial fibrillation.

Capranzano P, Miccichè E, D'Urso L, Privitera F, Tamburino C.

Expert Rev Cardiovasc Ther. 2013 Aug;11(8):959-73. doi: 10.1586/14779072.2013.818819. Epub 2013 Aug 19. Review.

PMID:
23957907
17.

Oral anticoagulant treatment in very elderly patients with atrial fibrillation.

Pengo V.

Compr Ther. 2001 Spring;27(1):7-10. Review.

PMID:
11280859
18.

Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerations.

Rosenberg DJ, Ansell J.

Hosp Pract (1995). 2012 Aug;40(3):50-7. doi: 10.3810/hp.2012.08.989. Review.

PMID:
23086094
19.

Oral anticoagulation: challenges in the case-management setting.

Lowery S, Haley K, Bussey HI.

Lippincotts Case Manag. 2005 Jan-Feb;10(1):39-50. Review.

PMID:
15685010
20.

Prevention of vascular events in patients with atrial fibrillation: evidence, guidelines, and practice.

Connolly SJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S52-5. Review.

PMID:
12950519

Supplemental Content

Support Center